Intraductal Papillary Mucinous Neoplasm
Conditions
Interventions
Sponsors
Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with confirmed main duct IPMN who are either unwilling or unable to undergo surgical resection.
Exclusion criteria
Exclusion criteria: 1. Patients unable to lie flat and/or tolerate the procedure; 2. Severe coagulation dysfunction; 3. Severe cardiac, pulmonary, or renal failure; 4. History of other malignant tumors or prior antitumor therapy; 5. History of previous pancreatic surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical success rate;Clinical success rate;Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of postoperative adverse events (including but not limited to: bleeding requiring endoscopic or interventional hemostasis; perforation confirmed by imaging or endoscopy; cholangitis (meeting the 2018 Tokyo Guidelines diagnostic criteria); pancreatitis (meeting the revised Atlanta criteria); stent-related complications (migration, occlusion, infection));Quality of life;Progression-free survival;Tumor marker CA19-9; | — |
Countries
China
Contacts
Public ContactLi Hongzhen
Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Outcome results
None listed